These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9437450)

  • 1. Assessing physical status in Alzheimer disease research.
    Warshaw G
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():66-72. PubMed ID: 9437450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of the impact of comorbid medical disease on bipolar disorder outcomes.
    Pirraglia PA; Biswas K; Kilbourne AM; Fenn H; Bauer MS
    J Affect Disord; 2009 Jun; 115(3):355-9. PubMed ID: 18930558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comorbidity indexes: review of the literature and application to studies of elderly population].
    Harboun M; Ankri J
    Rev Epidemiol Sante Publique; 2001 Jun; 49(3):287-98. PubMed ID: 11427831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of comorbidity: a review.
    Tobacman JK
    Clin Perform Qual Health Care; 1994; 2(1):23-32. PubMed ID: 10135440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and effectiveness research in Alzheimer disease.
    Clancy CM; Cooper JK
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():7-11. PubMed ID: 9437442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of comorbidity on costs for patients with Alzheimer disease.
    Kuo TC; Zhao Y; Weir S; Kramer MS; Ash AS
    Med Care; 2008 Aug; 46(8):839-46. PubMed ID: 18665064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving depression outcomes in older adults with comorbid medical illness.
    Harpole LH; Williams JW; Olsen MK; Stechuchak KM; Oddone E; Callahan CM; Katon WJ; Lin EH; Grypma LM; Unützer J
    Gen Hosp Psychiatry; 2005; 27(1):4-12. PubMed ID: 15694213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
    Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minor depression and physical outcome trajectories in heart failure and pulmonary disease.
    Koenig HG; Vandermeer J; Chambers A; Burr-Crutchfield L; Johnson JL
    J Nerv Ment Dis; 2006 Mar; 194(3):209-17. PubMed ID: 16534439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing the content of outcome measures in clinical trials on irritable bowel syndrome using the international classification of functioning, disability and health as a reference.
    Schönrich S; Brockow T; Franke T; Dembski R; Resch KL; Cieza A
    Rehabilitation (Stuttg); 2006 Jun; 45(3):172-80. PubMed ID: 16755436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life assessment: understanding its use as an outcome measure.
    Coons SJ; Kaplan RM
    Hosp Formul; 1993 May; 28(5):486-90, 492, 497-8. PubMed ID: 10125806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scales as outcome measures for Alzheimer's disease.
    Black R; Greenberg B; Ryan JM; Posner H; Seeburger J; Amatniek J; Resnick M; Mohs R; Miller DS; Saumier D; Carrillo MC; Stern Y
    Alzheimers Dement; 2009 Jul; 5(4):324-39. PubMed ID: 19560103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining and measuring outcomes for Alzheimer disease research.
    Gura C
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():196-8. PubMed ID: 9437468
    [No Abstract]   [Full Text] [Related]  

  • 18. Caregivers' assessments of preference-based quality of life in Alzheimer's disease.
    Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Low DV; Glick HA
    Alzheimers Dement; 2008 May; 4(3):203-11. PubMed ID: 18631969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for a multidisciplinary approach to cancer care.
    Ko C; Chaudhry S
    J Surg Res; 2002 Jun; 105(1):53-7. PubMed ID: 12069502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical status and complications in patients with Alzheimer disease: implications for outcome studies.
    Volicer L; Hurley AC
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():60-5. PubMed ID: 9437449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.